Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (910)	1/22/2002 7:09:45 PM
From: tom pope	Read Replies (1) of 3044

16:44 ET Millennium Pharm (MLNM) 20.23 -0.17: Reports Q4 net loss of $0.23 per share, $0.04 worse than the consensus estimate; reports Q4 revenues of $54.6 mln versus the current consensus estimate of $55.4 mln; updates guidance for FY02; expects revenues of "more than $400 mln" versus the current consensus estimate of $373 mln; expects a net loss in the range of $175-$200 mln; expects to end the year with a cash balance in excess of $1.7 billion with approximately $250 million in long-term outstanding debt. Trying to buy a little after hours at 19.60, but not getting filled.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next